Mutanome Engineered RNA Immunotherapy: Towards Patient-Centered Tumor Vaccination

Por Vormehr, Mathias, Schrörs, Barbara, Boegel, Sebastian, Löwer, Martin, Türeci, Özlem, Sahin, Ugur
Publicado no J Immunol Res (2015)

CIMT 2017: Anniversary symposium - Report on the 15th CIMT Annual Meeting of the Association for Cancer Immunotherapy

Por Kranz, Lena M., Beck, Jan D., Grunwitz, Christian, Hotz, Christian, Vormehr, Mathias, Diken, Mustafa
Publicado no Hum Vaccin Immunother (2017)

CIMT 2014: Next waves in cancer immunotherapy - Report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, Germany

Por Diken, Mustafa, Boegel, Sebastian, Grunwitz, Christian, Kranz, Lena M., Reuter, Kerstin, van de Roemer, Niels, Vascotto, Fulvia, Vormehr, Mathias, Kreiter, Sebastian
Publicado no Hum Vaccin Immunother (2014)

CIMT 2016: Mechanisms of efficacy in cancer immunotherapy — Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10–12 2016, Mainz, Germany

Por Kranz, Lena M., Birtel, Matthias, Hilscher, Lina, Grunwitz, Christian, Petschenka, Jutta, Vascotto, Fulvia, Vormehr, Mathias, Voss, Ralf-Holger, Kreiter, Sebastian, Diken, Mustafa
Publicado no Hum Vaccin Immunother (2016)

CIMT 2015: The right patient for the right therapy - Report on the 13th annual meeting of the Association for Cancer Immunotherapy

Por Kranz, Lena M, Birtel, Matthias, Krienke, Christina, Grunwitz, Christian, Petschenka, Jutta, Reuter, Kerstin C, van de Roemer, Niels, Vascotto, Fulvia, Vormehr, Mathias, Kreiter, Sebastian, Diken, Mustafa
Publicado no Hum Vaccin Immunother (2015)

Mutant MHC class II epitopes drive therapeutic immune responses to cancer

Por Kreiter, Sebastian, Vormehr, Mathias, van de Roemer, Niels, Diken, Mustafa, Löwer, Martin, Diekmann, Jan, Boegel, Sebastian, Schrörs, Barbara, Vascotto, Fulvia, Castle, John C., Tadmor, Arbel D., Schoenberger, Stephen P., Huber, Christoph, Türeci, Özlem, Sahin, Ugur
Publicado no Nature (2015)